Project Grant R61CA287408
Award Date
9/17/24
Completion Date
8/31/27
Dollars Obligated
$456K
Federal Agency
National Cancer Institute
Federal Grant Program
93.396
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This $437,250 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) will support advanced computational approaches for integrating single-cell multi-omics data. Over the 5-year project period starting August 2025, the University of Pittsburgh will develop novel integration methods to combine single-cell RNA sequencing, ATAC-seq, and cytometry data, as well as algorithms for spatial transcriptomics and...
This Project Grant award, totaling $450,904, was provided by the National Cancer Institute (NCI) under the Cancer Biology Research federal grant program (CFDA 93.396). The grant was awarded to the Battelle Memorial Institute's Pacific Northwest National Laboratory to develop a single-cell (phospho-)proteomics platform to enable robust and rapid analysis of the tumor microenvironment at both the proteome and phosphoproteome levels. The key objectives are to address three major challenges: 1)...
This $286,326 federal Project Grant award from the National Institutes of Health (NIH) Common Fund supports the development of new machine learning methods to analyze spatial transcriptome data from multiple NIH Common Fund programs, including HuBMAP and SenNet. The key products and services to be delivered under this 1-year award, which runs from June 2025 to May 2026, include: Creating a scalable, platform-agnostic framework using pre-trained single-cell RNA-seq foundation models to...
The National Human Genome Research Institute (NHGRI) awarded a $400,000 Project Grant (CFDA 93.172 - Human Genome Research) to the University of Washington to develop new single-cell multi-omic technologies for studying the relationship between three-dimensional genome organization and gene expression. Specifically, the grant will fund the development of CARE-Seq, a novel method to jointly measure whole-genome chromatin interactions and gene expression in the same single cells from complex...
This Project Grant award of $418,176 from the National Cancer Institute (NCI), under the Cancer Biology Research federal grant program (CFDA 93.396), is supporting the continued advanced development and validation of nucleic acid cytometry technology at the Sloan-Kettering Institute for Cancer Research. The goal is to enable the programmable enrichment and profiling of rare cell populations from tumor and tissue samples, overcoming limitations of current antibody-based cell sorting methods....
This $658,336 Project Grant was awarded by the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to Rarecyte, Inc., a for-profit organization in Seattle, WA. The grant supports the development of the ORION2 method, an advanced approach to acquiring highly multiplexed tissue images from formaldehyde-fixed, paraffin-embedded (FFPE) specimens. This "attention-based" imaging technology will focus on the most informative tissue...
This $372,628 Project Grant was awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to the University of Chicago on September 12, 2025. The grant supports the development of a large-format spatially resolved transcriptomics (ST) profiling platform called Array-SEQ, which aims to enable detailed spatiomolecular analyses of cancer samples across a large number of patient cohorts. The project seeks to overcome key limitations of existing ST technologies,...
This Project Grant award, valued at $424,734 and provided by the National Cancer Institute (CFDA 93.396 - Cancer Biology Research), supports the development of a novel spatial proteomics approach to analyze the tumor microenvironment. The University of Illinois, the award recipient, will integrate 3D microscopy techniques with bottom-up proteomic assays to profile the proteomes of specific immune cells within different subregions of a mouse tumor. This innovative methodology aims to...
This $339,300 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports Triangle Biotechnology's development of a nanodroplet-enhanced sonication technology called ChromExtract. The goal is to enable high-quality, high-yield, and consistent chromatin extraction from formalin-fixed, paraffin-embedded (FFPE) tissue samples for downstream chromatin profiling and accessibility analyses. The...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $230,010 to the University of Chicago to develop and apply a novel epigenome sequencing platform called Glycosylase-Implemented Epigenome Sequencing (GLIMP-SEQ). The goal is to enable highly sensitive and accurate profiling of 5-methylcytosine (5mC) modifications in degraded clinical samples, such as formalin-fixed, paraffin-embedded tissues and cell-free DNA. GLIMP-SEQ...